According to FutureWise analysis the market for Liver Transplantation in 2023 is US$ 1.4 billion, and is expected to reach US$ 2.36 billion by 2031 at a CAGR of 6.72%.
A liver transplant or hepatic transplant is a procedure performed on a patient suffering from liver failure and unable to perform normal metabolic functions such as synthesising carbohydrates, proteins and fats. There are several diseases that cause liver failure, including liver cirrhosis, cystic fibrosis, hemochromatosis, primary biliary cirrhosis, primary sclerosing cholangitis, and Wilson's disease. In fact, liver transplantation is the second most common transplant procedure after kidney transplantation, which indicates that liver disease is a common and serious issue. Generally, liver transplants use livers from deceased donors, but they can also come from living donors (allograft). The increasing awareness and spending on healthcare globally is expected to drive the demand for liver transplants during the study period.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Liver Transplantation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Liver Transplantation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.